Paysign, Inc. (PAYS) Stock Analysis

Paysign Targets $117M Revenue as Patient-Affordability Business Surges

Fri, August 28, 2026 at 8:02 AM UTC 3 min read

Paysign has set a revenue target of $117 million, driven by significant growth in its patient-affordability business. This surge reflects increasing demand for financial solutions in healthcare, positioning Paysign as a key player in the market. For investors, this growth trajectory suggests potential for strong financial performance and enhanced shareholder value in the coming quarters.

Read full article →

Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock?

Wed, August 26, 2026 at 4:00 PM UTC 3 min read

Paysign (PAYS) has been upgraded to a "Buy" rating by analysts, indicating a positive outlook for the stock. This upgrade suggests that the company's financial health and growth prospects are improving, making it an attractive option for investors seeking potential gains. As a result, investors may want to consider this upgrade when evaluating their portfolios and investment strategies.

Read full article →